• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Exosome Therapeutics Pipeline Expanding at an Immense Rate As 55+ Key Companies are Actively Working In the Domain by DelveInsight

September 22nd, 2022 DelveInsight Business Research Releases

Exosomes are a relatively new therapy in the field of regenerative medicine, and there has a been significant advancements in the domain in recent years. Due to their appropriate size, property, and numerous pathobiological characteristics, Exosome has the promising potential to manage the treatment outcome for various musculoskeletal disorders, neurodegenerative disorders, infectious diseases, and cardiovascular disorders. As per DelveInsight’s assessment, the Exosome pipeline possesses 70+ emerging drugs from preclinical to late-stage clinical development stages expected to be launched in the near future. The therapeutic pipeline consists of emerging products based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. 

DelveInsight’s ‘Exosomes Pipeline Insight 2022‘ report provides comprehensive global coverage of marketed therapies and pipeline products in various stages of clinical development. It also covers the major pharmaceutical companies working to advance the pipeline space and assess the future growth potential in the therapeutic market.

Key Takeaways from the Exosomes Pipeline Insight Report

  • The report provides a detailed assessment of the 70+ pipeline products under development by 55+ players in the Exosomes therapeutics landscape.
  • Some of the key companies in the Exosomes Therapeutics segment include Direct Biologics, Capricor, Regeneus, AVEM HealthCare, Aegle Therapeutics, Organicell Regenerative Medicine, Codiak Biosciences, United Therapeutics, ArunA Biomedical, Evox Therapeutics, MolecuVax, Versatope Therapeutics, Lamellar Biomedical, Azymus Therapeutics, Alxerion Biotech, Avalon GloboCare, Capricor Therapeutics, and several other.
  • Promising Exosomes pipeline products in various stages of development include ExoFlo (Direct Biologics), Progenza (Regeneus), Exosome-electroporated dendritic cells as a vaccine for cancer therapy (ExoCyte Therapeutics), AVA-201 (Avalon GloboCare), RGLS4326 (Regulus Therapeutics Inc.), exoIL-12 (Codiak BioSciences), DB-001 (Direct Biologics, LLC), CAP-1002 (Capricor Inc.), AGLE 102 (Aegle Therapeutics) and others.
  • Among all the major players working in the domain, currently, Direct Biologics has its Exosomes drug candidates in the most advanced stage of clinical development.

Learn more about the recent advances in the therapeutics segment @ Exosomes’s Clinical Trials Activities

DelveInsight’s Report covers around 70+ pipeline products under different phases of clinical development like –

  • Late-stage products (Phase III and
  • Mid-stage products (Phase II and
  • Early-stage products (Phase I/II and Phase I)
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidate
  • Route of Administration

Exosomes: Overview

Exosomes are a type of extracellular vesicle, a family of nanometer-scale, biomolecule-filled, lipid-wrapped packages that contain constituents (protein, DNA, and RNA) of the cells that secrete them. Due to their protein and lipid content, exosomes are special, providing an additional hint for their identification. Exosomes can be a highly heterogeneous population with distinct abilities to induce a complex biological response. 

Exosomes are nano-sized vesicles capable of transferring DNAs, micro RNAs, non-coding RNAs, and lipids, with or without direct cell-to-cell contact, representing a novel method of intracellular communication. Exosomes have therapeutic potential to control many diseases, along with aiding in disease diagnosis. Globally, several studies are going on to evaluate the role of exosomes in the diagnosis and treatment of various pathologies.

Explore more about the therapeutic applications of exosomes @ Clinical Trials for Exosome-Based Therapeutics

Exosomes Pipeline Outlook

  • The report assesses the emerging products in terms of mono and combination therapies by stage/different phases. The emerging products are further segmented on various routes of administration (ROA).
  • This report covers the number of therapies by types of molecules present in different phases, targets on which the drugs act, and their mechanism of action (MOA). 
  • The report also provides detailed insights about companies that are actively working in the domain and their active & inactive (dormant or discontinued) projects.

Scope of the Exosomes Pipeline Insight Report 

  • Coverage: Global 
  • Therapeutic Assessment By Product Type: Mono, Combination, and Mono/Combination
  • Therapeutic Assessment By Clinical Stages: Late-stage products (Phase II and Phase II/III), Mid-stage products (Phase II and Phase II/III), Early-stage products (Phase I/II and Phase I), along with the details of pre-clinical and discovery stage candidates, discontinued & inactive candidates.
  • Therapeutics Assessment By Route of Administration: Infusion, Intradermal, Intramuscular, Intranasal, Intravaginal, Oral, Parenteral, Subcutaneous, Topical.
  • Therapeutics Assessment By Molecule Type: Vaccines, Monoclonal Antibody, Peptides, Polymer, Small molecule.
  • Therapeutics Assessment By Mechanism of Action: MIRN17 microRNA inhibitors; RNA interference, Collagen type VII replacements; Cell replacements
  • Key Companies in the Exosomes Therapeutics Segment: Direct Biologics, Capricor (NASDAQ: CAPR), Regeneus (ASX: RGS), AVEM HealthCare, Aegle Therapeutics (NASDAQ: EGRX), Organicell Regenerative Medicine (OTCMKTS: OCEL), Codiak Biosciences (NASDAQ: CDAK), United Therapeutics (NASDAQ: UTHR), ArunA Biomedical, Evox Therapeutics, MolecuVax, Versatope Therapeutics, Lamellar Biomedical, Azymus Therapeutics, Alxerion Biotech, Avalon GloboCare (NASDAQ: AVCO), Capricor Therapeutics (NASDAQ: CAPR), and several other.
  • Key Exosomes Pipeline Products: ExoFlo, Progenza, Exosome-electroporated dendritic cells as a vaccine for cancer therapy, AVA-201, RGLS4326, exoIL-12, DB-001, CAP-1002, AGLE 102, LAMELLASOME IPF-NA, exoSTING, ET-08, Unexisome, CAP 2003, AZ 001, VT 105, and others.

Get the sample PDF for a more detailed understanding of therapeutic developments and updated clinical trials @ Exosomes Pipeline Assessment

Table of Contents

1. Exosomes Pipeline Report Introduction
2. Exosomes Pipeline Report Executive Summary
3. Exosomes Pipeline: Overview
4. Analytical Perspective In-depth Commercial Assessment
5. Exosomes Clinical Trial Assessment
6. Exosomes Pipeline: Late Stage Products (Pre-registration)
7. Exosomes Pipeline: Late Stage Products (Phase III)
8. Exosomes Pipeline: Mid Stage Products (Phase II)
9. Exosomes Pipeline: Early Stage Products (Phase I)
10. Exosomes Therapeutics Pipeline Assessment
11. Inactive Products in the Exosomes Pipeline
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Key Companies
14. Key Products in the Exosomes Pipeline
15. Unmet Needs
16. Market Drivers and Barriers
17. Future Perspectives and Conclusion
18. Analyst Views
19. Appendix

Download the Sample Report for More Details into the Clinical Trial Landscape @ Exosomes Global Pipeline Insight

Other Trending Healthcare Report by DelveInsight

Goitre Market |  Thymus Cancer Market | US Healthcare Outlook Report | Venous Stenosis Market | Negative Pressure Wound Therapy Systems Market | Global Kinase Inhibitor in Autoimmune Diseases Market | Metrorrhagia Market | Dysfunctional Uterine Bleeding Market | Hypereosinophilic Syndrome Market | Age-related Vision Dysfunction Market | Dental Lasers Market | CRISPR Therapies Pipeline Insight | Cell And Gene Therapy For Multiple Myeloma Market | Drug Hypersensitivity Market | Dysthymia Market | Persistent Depressive Disorder Market | Cancer Vaccines Market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

Contact Us

Shruti Thakur

info@delveinsight.com

+1(919)321-6187

www.delveinsight.com

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email